What is the global immuno-oncology market size in 2025?

The immuno-oncology market is projected to reach US$56.8 Bn in 2025.

What drives the immuno-oncology market?

The alarming rise in cancer incidence worldwide is intensifying the demand for more effective, personalized cancer therapies, driving the market.

What is the growth rate for the immuno-oncology market?

The market is poised to witness a CAGR of 22.7% from 2025 to 2032.

What are the key market opportunities?

Key market opportunities include breakthroughs in biomarker detection assays, next-generation sequencing, and AI-driven analytics, which collectively facilitate more accurate patient selection and adaptive immunotherapy regimens.

Who are the key players in the immuno-oncology market?

Key players include Bristol-Myers Squibb Company, Merck & Co., Inc., and Pfizer Inc.

Table of Content - Immuno-Oncology Market Size, Share, Trends, Growth, and Forecasts for 2025

Executive Summary
1. Global Immuno-Oncology Market Snapshot, 2025 and 2032
2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Key Trends
3. Macro-economic Factors
  1. Global Sectoral Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Tool Adoption Analysis
2. Regulatory Landscape
3. Value Chain Analysis
4. PESTLE Analysis
5. Porter’s Five Force Analysis
Price Analysis, 2024A
1. Key Highlights
2. Key Factors Impacting Deployment Costs
3. Pricing Analysis, By Treatment Type
Global Immuno-Oncology Market Outlook
1. Key Highlights
  1. Market Volume (Units) Projections
  2. Market Size (US$ Bn) and Y-o-Y Growth
  3. Absolute $ Opportunity
2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
  1. Historical Market Size (US$ Bn) Analysis, 2019-2024
  2. Current Market Size (US$ Bn) Analysis and Forecast, 2025 - 2032
3. Global Immuno-Oncology Market Outlook: Treatment Type
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Treatment Type, 2019 - 2024
  3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Treatment Type, 2025 - 2032
    1. Immune Checkpoint Inhibitors
    2. CAR-T Cell Therapy
    3. Cancer Vaccines
    4. Bispecific Antibodies
    5. Monoclonal Antibodies
    6. Oncolytic Viruses
    7. Cytokine Therapy
    8. Others
  4. Market Attractiveness Analysis: Treatment Type
4. Global Immuno-Oncology Market Outlook: End-user
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By End-user, 2019 - 2024
  3. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025 - 2032
    1. Hospitals
    2. Specialty Clinics
    3. Retail Pharmacies
    4. Others
  4. Market Attractiveness Analysis: End-user
5. Global Immuno-Oncology Market Outlook: Disease Type
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By Disease Type, 2019 - 2024
  3. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025 - 2032
    1. Lung Cancer
    2. Breast Cancer
    3. Colorectal Cancer
    4. Prostate Cancer
    5. Melanoma
    6. Ovarian Cancer
    7. Others
  4. Market Attractiveness Analysis: Disease Type
6. Global Immuno-Oncology Market Outlook: Assay
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By Assay, 2019 - 2024
  3. Current Market Size (US$ Bn) Analysis and Forecast, By Assay, 2025 - 2032
    1. Polymerase Chain Reaction (PCR)
    2. Immunoassay
    3. Next Generation Sequencing (NGS)
    4. Flow Cytometry
    5. In-Situ Hybridization (ISH)
  4. Market Attractiveness Analysis: Assay
Global Immuno-Oncology Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2024
3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025 - 2032
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Immuno-Oncology Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Treatment Type
  3. By End-user
  4. By Disease Type
  5. By Assay
3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
  1. U.S.
  2. Canada
4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Treatment Type, 2025 - 2032
  1. Immune Checkpoint Inhibitors
  2. CAR-T Cell Therapy
  3. Cancer Vaccines
  4. Bispecific Antibodies
  5. Monoclonal Antibodies
  6. Oncolytic Viruses
  7. Cytokine Therapy
  8. Others
5. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025 - 2032
  1. Hospitals
  2. Specialty Clinics
  3. Retail Pharmacies
  4. Others
6. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025-2032
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Ovarian Cancer
  7. Others
7. Current Market Size (US$ Bn) Analysis and Forecast, By Assay, 2025-2032
  1. Polymerase Chain Reaction (PCR)
  2. Immunoassay
  3. Next Generation Sequencing (NGS)
  4. Flow Cytometry
  5. In-Situ Hybridization (ISH)
8. Market Attractiveness Analysis
Europe Immuno-Oncology Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Treatment Type
  3. By End-user
  4. By Disease Type
  5. By Assay
3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Treatment Type, 2025 - 2032
  1. Immune Checkpoint Inhibitors
  2. CAR-T Cell Therapy
  3. Cancer Vaccines
  4. Bispecific Antibodies
  5. Monoclonal Antibodies
  6. Oncolytic Viruses
  7. Cytokine Therapy
  8. Others
5. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025 - 2032
  1. Hospitals
  2. Specialty Clinics
  3. Retail Pharmacies
  4. Others
6. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025-2032
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Ovarian Cancer
  7. Others
7. Current Market Size (US$ Bn) Analysis and Forecast, By Assay, 2025-2032
  1. Polymerase Chain Reaction (PCR)
  2. Immunoassay
  3. Next Generation Sequencing (NGS)
  4. Flow Cytometry
  5. In-Situ Hybridization (ISH)
8. Market Attractiveness Analysis
East Asia Immuno-Oncology Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Treatment Type
  3. By End-user
  4. By Disease Type
  5. By Assay
3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
  1. China
  2. Japan
  3. South Korea
4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Treatment Type, 2025 - 2032
  1. Immune Checkpoint Inhibitors
  2. CAR-T Cell Therapy
  3. Cancer Vaccines
  4. Bispecific Antibodies
  5. Monoclonal Antibodies
  6. Oncolytic Viruses
  7. Cytokine Therapy
  8. Others
5. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025 - 2032
  1. Hospitals
  2. Specialty Clinics
  3. Retail Pharmacies
  4. Others
6. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025-2032
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Ovarian Cancer
  7. Others
7. Current Market Size (US$ Bn) Analysis and Forecast, By Assay, 2025-2032
  1. Polymerase Chain Reaction (PCR)
  2. Immunoassay
  3. Next Generation Sequencing (NGS)
  4. Flow Cytometry
  5. In-Situ Hybridization (ISH)
8. Market Attractiveness Analysis
South Asia & Oceania Immuno-Oncology Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Treatment Type
  3. By End-user
  4. By Disease Type
  5. By Assay
3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Treatment Type, 2025 - 2032
  1. Immune Checkpoint Inhibitors
  2. CAR-T Cell Therapy
  3. Cancer Vaccines
  4. Bispecific Antibodies
  5. Monoclonal Antibodies
  6. Oncolytic Viruses
  7. Cytokine Therapy
  8. Others
5. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025 - 2032
  1. Hospitals
  2. Specialty Clinics
  3. Retail Pharmacies
  4. Others
6. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025-2032
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Ovarian Cancer
  7. Others
7. Current Market Size (US$ Bn) Analysis and Forecast, By Assay, 2025-2032
  1. Polymerase Chain Reaction (PCR)
  2. Immunoassay
  3. Next Generation Sequencing (NGS)
  4. Flow Cytometry
  5. In-Situ Hybridization (ISH)
8. Market Attractiveness Analysis
Latin America Immuno-Oncology Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Treatment Type
  3. By End-user
  4. By Disease Type
  5. By Assay
3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Treatment Type, 2025 - 2032
  1. Immune Checkpoint Inhibitors
  2. CAR-T Cell Therapy
  3. Cancer Vaccines
  4. Bispecific Antibodies
  5. Monoclonal Antibodies
  6. Oncolytic Viruses
  7. Cytokine Therapy
  8. Others
5. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025 - 2032
  1. Hospitals
  2. Specialty Clinics
  3. Retail Pharmacies
  4. Others
6. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025-2032
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Ovarian Cancer
  7. Others
7. Current Market Size (US$ Bn) Analysis and Forecast, By Assay, 2025-2032
  1. Polymerase Chain Reaction (PCR)
  2. Immunoassay
  3. Next Generation Sequencing (NGS)
  4. Flow Cytometry
  5. In-Situ Hybridization (ISH)
8. Market Attractiveness Analysis
Middle East & Africa Immuno-Oncology Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Treatment Type
  3. By End-user
  4. By Disease Type
  5. By Assay
3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Treatment Type, 2025 - 2032
  1. Immune Checkpoint Inhibitors
  2. CAR-T Cell Therapy
  3. Cancer Vaccines
  4. Bispecific Antibodies
  5. Monoclonal Antibodies
  6. Oncolytic Viruses
  7. Cytokine Therapy
  8. Others
5. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025 - 2032
  1. Hospitals
  2. Specialty Clinics
  3. Retail Pharmacies
  4. Others
6. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Type, 2025-2032
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Ovarian Cancer
  7. Others
7. Current Market Size (US$ Bn) Analysis and Forecast, By Assay, 2025-2032
  1. Polymerase Chain Reaction (PCR)
  2. Immunoassay
  3. Next Generation Sequencing (NGS)
  4. Flow Cytometry
  5. In-Situ Hybridization (ISH)
8. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2024
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. Bristol-Myers Squibb Company
    1. Overview
    2. Segments and Deployments
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Merck & Co., Inc.
  3. Pfizer Inc.
  4. Roche Holding AG
  5. Novartis AG
  6. Johnson & Johnson Services, Inc.
  7. AstraZeneca PLC
  8. AbbVie Inc.
  9. BioNTech SE
  10. Gilead Sciences, Inc.
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Immuno-Oncology Market Size, Share, Trends, Growth, and Forecasts for 2025 - 2032

Immuno-Oncology Market by Treatment Type (Immune Checkpoint Inhibitors, CAR-T Cell Therapy, Cancer Vaccines, Others), End-user (Hospitals, Others), Disease Type (Lung Cancer, Breast Cancer, Others), Assay (PCR, Others), and Regional Analysis for 2025 - 2032

Quick Links

Our Partners

Secure Payments Through